Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Daiki Ueno

ResearcherPublications, citations & collaboration network

Daiki Ueno is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 97 works, 805 citations, an h-index of 16 and an i10-index of 21.

97
Works
805
Citations
16
h-index
21
i10-index

How has Daiki Ueno's publication output changed over time?

ScholarIQpublication output · 2012–2023

Output grew0% over the shown period — from 1 works in 2012 to 1 in 2023.

1
1
2
1
1
2
1
1
20122014201620172018201920202023

What are the most-cited papers on Daiki Ueno?

ScholarIQmost cited works
Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair
Parker L. Sulkowski, Ranjini K. Sundaram, Sebastian Oeck, Christopher D. Corso, Yanfeng Liu, Seth Noorbakhsh, Monica Niger, Marta Boeke, Daiki Ueno, Aravind Kalathil, Xun Bao, Jing Li, Brian Shuch, Ranjit S. Bindra, Peter M. Glazer
S137905309. 2018218 Citations
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
Daiki Ueno, Masahiro Yao, Ukihide Tateishi, Ryogo Minamimoto, Kazuhide Makiyama, Narihiko Hayashi, Futoshi Sano, Takayuki Murakami, Takeshi Kishida, Takeshi Miura, Kazuki Kobayashi, Sumio Noguchi, Ichiro Ikeda, Yoshiharu Ohgo, Tomio Inoue, Yoshinobu Kubota, Noboru Nakaigawa
BMC Cancer. 201275 CitationsOPEN ACCESS
FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer
Blake R. Wilde, Nishma Chakraborty, Nedas Matulionis, Stephanie Hernandez, Daiki Ueno, Michayla E. Gee, Edward D. Esplin, Karen Ouyang, Keith Nykamp, Brian Shuch, Heather R. Christofk
Cancer Discovery. 202373 CitationsOPEN ACCESS
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma
Noboru Nakaigawa, Keiichi Kondo, Ukihide Tateishi, Ryogo Minamimoto, Tomohiro Kaneta, Kazuhiro Namura, Daiki Ueno, Kazuki Kobayashi, Takeshi Kishida, Ichiro Ikeda, Hisashi Hasumi, Kazuhide Makiyama, Yoshinobu Kubota, Tomio Inoue, Masahiro Yao
BMC Cancer. 201658 CitationsOPEN ACCESS
Glutamine and the Tumor Immune Microenvironment
Izak Faiena, Daiki Ueno, Brian Shuch
European Urology. 201936 Citations

Related on ScholarIQ

Yokohama City University Medical Center
Institution
Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair
Paper
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
Paper
FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer
Paper
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma
Paper
Glutamine and the Tumor Immune Microenvironment
Paper
470M+ articles · free account